Skip to content

ABT

Abbott Laboratories

Free cash flow, 2025
$7.4B
YoY, 2025
+16.4%
5-year CAGR
+5.3%
10-year CAGR
+14.8%

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025$7.4B+16.4%
2024$6.4B+25.5%
2023$5.1B−35.2%
2022$7.8B−9.8%
2021$8.6B+51.1%
2020$5.7B+27.3%
2019$4.5B−8.3%
2018$4.9B+10.6%
2017$4.4B+113.0%
2016$2.1B+12.2%
2015$1.9B−28.6%
2014$2.6B+19.2%
2013$2.2B−71.0%
2012$7.5B+0.5%
2011$7.5B−3.1%
2010$7.7B+24.8%
2009$6.2B+8.4%
2008$5.7B+61.8%
2007$3.5B—